These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15842807)

  • 1. [Effects of interaction between vascular endothelial cells and monocytes on expression of matrix metalloproteinase-2 and of tissue inhibitor of metalloproteinases 2 and regulation of pravastatin].
    Zheng W; Yang XH
    Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):105-8. PubMed ID: 15842807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells.
    Izidoro-Toledo TC; Guimaraes DA; Belo VA; Gerlach RF; Tanus-Santos JE
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jun; 383(6):547-54. PubMed ID: 21448567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.
    Wang C; Chen Z; Li Z; Cen J
    Leuk Res; 2010 Aug; 34(8):1083-90. PubMed ID: 20138666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
    Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
    J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2.
    Schwartz JD; Monea S; Marcus SG; Patel S; Eng K; Galloway AC; Mignatti P; Shamamian P
    J Surg Res; 1998 Apr; 76(1):79-85. PubMed ID: 9695744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of preeclampsia and oxygen environment on endothelial release of matrix metalloproteinase-2.
    Merchant SJ; Narumiya H; Zhang Y; Guilbert LJ; Davidge ST
    Hypertens Pregnancy; 2004; 23(1):47-60. PubMed ID: 15117600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1 -MMP) compartment of proMMP-2 activation in MG-63 cells.
    Luo XH; Liao EY
    Horm Metab Res; 2001 Jul; 33(7):383-8. PubMed ID: 11507673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity.
    Lafleur MA; Forsyth PA; Atkinson SJ; Murphy G; Edwards DR
    Biochem Biophys Res Commun; 2001 Mar; 282(2):463-73. PubMed ID: 11401482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-1 expression by interaction between monocytes and vascular endothelial cells.
    Hojo Y; Ikeda U; Takahashi M; Sakata Y; Takizawa T; Okada K; Saito T; Shimada K
    J Mol Cell Cardiol; 2000 Aug; 32(8):1459-68. PubMed ID: 10900172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.
    Janowska-Wieczorek A; Marquez LA; Matsuzaki A; Hashmi HR; Larratt LM; Boshkov LM; Turner AR; Zhang MC; Edwards DR; Kossakowska AE
    Br J Haematol; 1999 May; 105(2):402-11. PubMed ID: 10233411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite effects of high glucose on MMP-2 and TIMP-2 in human endothelial cells.
    Ho FM; Liu SH; Lin WW; Liau CS
    J Cell Biochem; 2007 May; 101(2):442-50. PubMed ID: 17203468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells.
    Tsai MY; Yang RC; Wu HT; Pang JH; Huang ST
    Cancer Lett; 2011 Nov; 310(2):198-206. PubMed ID: 21788102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloprotein-9 activation under cell-to-cell interaction between endothelial cells and monocytes: possible role of hypoxia and tumor necrosis factor-α.
    Yamamoto Y; Osanai T; Nishizaki F; Sukekawa T; Izumiyama K; Sagara S; Okumura K
    Heart Vessels; 2012 Nov; 27(6):624-33. PubMed ID: 22234512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.
    Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R
    Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
    Monea S; Lehti K; Keski-Oja J; Mignatti P
    J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production.
    Amorino GP; Hoover RL
    Am J Pathol; 1998 Jan; 152(1):199-207. PubMed ID: 9422537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion.
    Cheng XW; Kuzuya M; Nakamura K; Liu Z; Di Q; Hasegawa J; Iwata M; Murohara T; Yokota M; Iguchi A
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1864-70. PubMed ID: 16051878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.